Showing results (851-860 of 1,524) with videos related to

Sort By:
Pageof 153
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Modeling and simulation in clinical pharmacology and dose findingA Staab, E Rook, M Maliepaard, et al.
CPT: Pharmacometrics & Systems Pharmacology|July 10, 2013
Metasignatures identify two major subtypes of breast cancerQ Duan, Y Kou, N R Clark, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 4, 2013
Modeling Alzheimer's Disease Progression Using Disease Onset Time and Disease Trajectory Concepts Applied to CDR-SOB Scores From ADNII Delor, J-E Charoin, R Gieschke, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 28, 2018
Establishing a Multidisciplinary Framework to Study Drug-Drug Interactions of Hormonal Contraceptives: An Invitation to CollaborateLawrence J Lesko, Valvanera Vozmediano, Joshua D Brown, et al.
CPT: Pharmacometrics & Systems Pharmacology|April 21, 2019
Optimal Scheduling of Bevacizumab and Pemetrexed/Cisplatin Dosing in Non-Small Cell Lung CancerBenjamin K Schneider, Arnaud Boyer, Joseph Ciccolini, et al.
CPT: Pharmacometrics & Systems Pharmacology|September 30, 2018
Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status EpilepticusLawrence C Ku, Christoph P Hornik, Ryan J Beechinor, et al.
CPT: Pharmacometrics & Systems Pharmacology|October 13, 2018
A Novel PBPK Modeling Approach to Assess Cytochrome P450 Mediated Drug-Drug Interaction Potential of the Cytotoxic Prodrug EvofosfamideChristian Lüpfert, Martin Dyroff, Oliver von Richter, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 11, 2018
First-Pass CYP3A-Mediated Metabolism of Midazolam in the Gut Wall and Liver in Preterm NeonatesJanneke M Brussee, Huixin Yu, Elke H J Krekels, et al.
CPT: Pharmacometrics & Systems Pharmacology|May 12, 2019
Concentration-QT Modeling Following Inhalation of the Novel Inhaled Phosphodiesterase-4 Inhibitor CHF6001 in Healthy Volunteers Shows an Absence of QT ProlongationKoen Jolling, Angela Äbelö, Nicolas Luyckx, et al.
CPT: Pharmacometrics & Systems Pharmacology|November 12, 2019
Population Pharmacokinetics of Ipilimumab in Combination With Nivolumab in Patients With Advanced Solid TumorsKinjal Sanghavi, Jason Zhang, Xiaochen Zhao, et al.
Pageof 153